A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism
CA 2497890 A1 · Owner: Bussolino, Federico · Inventors: Marchio, Serena; Bussolino, Federico
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to the finding that TAT interacts with gp120 at the cell surface and enhances HIV-1 entry into host cells. This invention also discloses modulators of this interaction particularly peptides that mimic the , region of gp120 involved in this interaction. These peptides interfere with TAT-mediated enhancement of infection regardless of virus strain and are , therefore suitable for the development in general of broad-range drugs against AIDS and other infectious diseases induced by HIV-1 related pathogens and , specifically for a class of chemicals active in the reduction or abrogation of virus and infectivity spreading.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 12, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 12, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 12, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.